vitamin d (d2 + d3), international units

Vitamin D is a fat‑soluble vitamin that exists in two primary forms relevant to human nutrition: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Both are precursors to the biologically active hormone calcitriol but differ chemically in their side chain structures and sources. Vitamin D3 is produced in human skin after exposure to ultraviolet B radiation from sunlight and is also found in certain animal‑derived foods and supplements. Vitamin D2 is derived from plant sources and fungi and is used in fortified foods and some supplements. In the body, both forms are transported to the liver, where they are hydroxylated to form 25‑hydroxyvitamin D (25(OH)D), the major circulating form used clinically to assess vitamin D status. A second hydroxylation in the kidneys produces 1,25‑dihydroxyvitamin D, the active form that binds to vitamin D receptors throughout the body. Vitamin D is measured in International Units (IU) where 1 IU is equivalent to 0.025 micrograms of cholecalciferol or ergocalciferol. Although vitamin D is classified as a vitamin, it functions like a hormone due to its systemic effects, especially on calcium and phosphate metabolism. It plays a critical role in maintaining serum calcium and phosphate levels, which are essential for normal bone mineralization and preventing disorders such as rickets in children and osteomalacia in adults. The discovery of vitamin D dates back to the early 20th century when researchers identified the link between sunlight, dietary factors, and the prevention of rickets. This research led to the understanding that vitamin D is necessary for calcium absorption in the intestine and, ultimately, skeletal health. Today, deficiencies remain widespread globally due to limited sun exposure, especially in higher latitudes, and limited dietary sources. Blood levels of 25‑hydroxyvitamin D are used diagnostically to identify deficiency or insufficiency, with levels below approximately 12–20 ng/mL typically indicating deficiency. Beyond bone health, vitamin D receptors have been identified in numerous tissues, suggesting broader roles in immune regulation, muscle function, and cellular differentiation.

Vitamin D has well‑established roles in supporting skeletal health by enhancing intestinal absorption of calcium and phosphate, essential for bone mineralization and remodeling. Adequate vitamin D prevents rickets in children and osteomalacia in adults and reduces the risk of osteoporosis in older adults when combined with calcium intake. Vitamin D also modulates immune function, with receptors present in immune cells. Some evidence suggests that adequate serum 25‑hydroxyvitamin D levels support innate immunity and may reduce the risk or severity of certain infections, though supplementation for infection prevention outside of deficiency correction remains debated. Beyond bone and immunity, emerging research suggests roles for vitamin D in cardiovascular health, metabolic regulation, and neurological function. For example, a recent evidence synthesis highlights vitamin D’s involvement in extra‑renal tissues, prenatal health, brain function, and immune modulation, noting it may influence chronic disease processes beyond skeletal outcomes. However, major clinical trials show mixed findings on vitamin D supplementation’s effects on cardiovascular outcomes, with some large trials not demonstrating reduced risk of major adverse cardiovascular events in general populations. Vitamin D influences cell differentiation and proliferation, which has prompted research into potential roles in cancer prevention pathways. Experimental data show vitamin D receptors and active vitamin D metabolites may regulate gene expression related to cell cycle regulation, inflammation, and apoptosis. In vitro and animal studies support vitamin D’s regulatory effects on cellular growth, though large human trials have not conclusively confirmed cancer prevention benefits. Vitamin D also supports muscle function and neuromuscular coordination, with deficiency linked to greater risk of muscle weakness and fall risk in older adults. Some meta‑analyses suggest supplementation may improve muscle strength in deficient individuals. Additionally, vitamin D plays a role in insulin secretion and sensitivity, and low vitamin D status has been associated with higher risk of type 2 diabetes in observational studies. However, randomized trials have not consistently shown that supplementation improves glycemic outcomes. Optimal vitamin D status, reflected by serum 25‑hydroxyvitamin D levels of at least 20–30 ng/mL, is supported for bone health and calcium homeostasis, while emerging evidence suggests potential benefits in other systems. Overall, vitamin D exerts diverse effects across biological systems through its hormonal actions and gene regulatory mechanisms.

The amount of vitamin D needed varies by age, life stage, and exposure to sunlight. The NIH Office of Dietary Supplements provides Recommended Dietary Allowances (RDAs) based on maintaining bone health and normal calcium metabolism in healthy individuals. For infants up to 12 months, an Adequate Intake (AI) of 400 IU/day is set due to limited intake data, while children and most adults up to age 70 are recommended 600 IU/day. Adults over 70 require 800 IU/day to compensate for reduced skin synthesis with aging and maintain bone health. During pregnancy and lactation, the same RDA of 600 IU/day also applies. These RDAs assume minimal or no sun exposure since ultraviolet radiation from sunlight can significantly contribute to endogenous vitamin D synthesis. Many experts and organizations acknowledge that individuals with limited sun exposure, darker skin pigmentation, or obesity may require higher intakes to achieve similar blood levels of 25‑hydroxyvitamin D, with some clinical guidelines recommending 1,000–2,000 IU/day for maintenance of optimal serum levels of 40–60 ng/mL. Discussion of optimal levels continues as vitamin D research evolves, but the primary public health guidance aims to prevent deficiency and related bone diseases. Determining individual needs should consider baseline serum concentrations measured via the 25‑hydroxyvitamin D test, geographic location, season, sunscreen use, skin pigmentation, and body mass. Individuals with malabsorption syndromes or certain medical conditions may have markedly increased requirements. While sun exposure contributes substantially to vitamin D status, excessive unprotected sun exposure increases skin cancer risk, making dietary and supplemental intake crucial for many individuals. Overall, achieving and maintaining adequate vitamin D status benefits skeletal health and may contribute to systemic functions.

Vitamin D deficiency manifests with clinical and subclinical features that primarily reflect impaired calcium metabolism. Classic signs include bone pain and tenderness, muscle weakness, and increased risk of fractures due to compromised bone integrity. In children, severe deficiency leads to rickets—characterized by skeletal deformities, delayed growth, and widened wrist joints—while adults may develop osteomalacia, which presents with diffuse bone pain, muscle weakness, and difficulty walking. Insufficiency states can be subtler, leading to fatigue, mood disturbances such as depressive symptoms, and increased susceptibility to falls in older adults. Individuals with dark skin, limited sun exposure, obesity, older age, chronic kidney disease, and malabsorption conditions such as celiac or Crohn’s disease are at elevated risk for deficiency. Populations living in northern latitudes or who consistently use high SPF sunscreen may produce insufficient vitamin D through skin synthesis, resulting in low serum 25‑hydroxyvitamin D levels. Blood testing of serum 25‑hydroxyvitamin D (25(OH)D) is the clinical standard for assessing vitamin D status. Concentrations below approximately 12 ng/mL indicate deficiency, while levels between 12–20 ng/mL are considered insufficient, and levels above 20–30 ng/mL are generally regarded as sufficient for bone health. Deficiency remains widespread globally, particularly among older adults and minority populations. Diagnosis guides targeted supplementation regimens to restore adequate levels and alleviate symptoms. Early detection and management are essential to prevent progression to severe skeletal disorders and functional decline.

Very few foods naturally contain significant vitamin D, which is why fortified foods play a central role in meeting dietary needs. Fatty fish such as sockeye salmon, mackerel, and swordfish are among the richest natural sources, providing hundreds of International Units per serving. UV‑exposed mushrooms serve as one of the few plant‑based sources with substantial vitamin D due to their ability to synthesize vitamin D2 when exposed to ultraviolet light. Cod liver oil remains a potent source, though its high vitamin A content warrants mindful dosing. Fortified dairy products—milk, yogurt, and fortified plant milks (soy, almond)—are key contributors for those with limited fish intake. Breakfast cereals and fortified orange juice offer additional options, though levels vary by brand. Egg yolks contribute modest amounts and are useful dietary components alongside other sources. Food sources differ in the form of vitamin D they provide; animals primarily supply D3, while fortified foods and mushrooms may provide D2 or D3 depending on the fortificant. Bioavailability can vary, with vitamin D3 generally raising serum 25‑hydroxyvitamin D levels more effectively and for longer durations than D2. Combining dietary sources with sensible sun exposure and/or supplementation ensures adequate intake. Professional guidance is recommended for individuals with dietary restrictions or health conditions affecting absorption.

Vitamin D absorption occurs in the small intestine and is enhanced when dietary fat is present due to its fat‑soluble nature. Both vitamin D2 and D3 are absorbed via passive diffusion and participate in micelle formation with bile acids, facilitating uptake by intestinal cells. After absorption, vitamin D is transported with chylomicrons through the lymphatic system to the bloodstream, bound to vitamin D‑binding protein. Factors that enhance absorption include consumption with meals containing dietary fats. Conversely, conditions that impair fat absorption—such as pancreatic insufficiency, celiac disease, cystic fibrosis, or medications like orlistat—can reduce vitamin D uptake. The form of vitamin D influences bioavailability; vitamin D3 appears more effective than D2 at raising and maintaining serum 25‑hydroxyvitamin D levels. Aging, obesity, and certain chronic diseases do not significantly alter gut absorption but may affect storage and metabolism, necessitating adjusted intake for optimal status. Understanding these factors helps guide dietary strategies and supplementation when needed to achieve target serum levels.

Supplementation is appropriate for many individuals, especially those with limited sun exposure, darker skin pigmentation, older age, obesity, or conditions impairing fat absorption, as these groups often exhibit low vitamin D status. Supplements are available as vitamin D2 (ergocalciferol) and D3 (cholecalciferol), with evidence suggesting D3 may increase serum 25‑hydroxyvitamin D more effectively. Taking supplements with a meal containing fat enhances absorption. Routine supplementation may benefit individuals with confirmed deficiency, certain chronic conditions, or limited dietary sources. However, large randomized trials yield mixed results regarding the benefits of supplementation for outcomes such as cardiovascular events or fracture prevention in general populations. Clinical guidelines emphasize correcting deficiency rather than universal supplementation. Health care providers often personalize dosing based on serum 25‑hydroxyvitamin D levels and patient risk factors. While moderate supplementation within recommended limits (e.g., 600–2,000 IU daily) is generally safe, excessive dosing without medical supervision may lead to toxicity. Monitoring serum levels during supplementation helps ensure adequacy without exceeding safe thresholds. Genetic factors, baseline status, and concurrent medical therapies also inform individual dosage decisions.

Vitamin D is fat‑soluble, meaning excessive intake accumulates in body tissues and can lead to toxicity, though this is rare from food or sun exposure alone. The Tolerable Upper Intake Level for adults is set at 4,000 IU/day; chronic intake above this without medical supervision may increase risk of hypercalcemia, elevated blood calcium that can cause nausea, vomiting, weakness, frequent urination, kidney stones, arrhythmias, and in severe cases kidney damage. Toxicity typically results from excessive supplementation over time. Symptoms include gastrointestinal distress, dehydration, and neuropsychiatric manifestations. Extreme hypervitaminosis D may also affect bone health adversely by interfering with other fat‑soluble vitamins and causing soft tissue calcification. Monitoring blood calcium and serum 25‑hydroxyvitamin D levels helps prevent toxicity in high‑dose supplemented individuals, especially those with conditions like hyperparathyroidism or granulomatous diseases that increase sensitivity to vitamin D.

Vitamin D interacts with several medications that can influence its metabolism, absorption, or calcium‑related effects. Certain anticonvulsants (e.g., phenytoin, phenobarbital, carbamazepine) accelerate vitamin D breakdown, potentially lowering serum levels. Weight‑loss drugs like orlistat reduce fat absorption and can impair vitamin D uptake; spacing supplement doses and meals may mitigate this. Digoxin use with high vitamin D intake may risk elevated calcium and increase digoxin toxicity potential, particularly affecting cardiac rhythm. Thiazide diuretics decrease calcium excretion; combined with vitamin D, this can raise hypercalcemia risk, necessitating clinical monitoring. Some antibiotics such as rifampin and isoniazid affect enzyme systems involved in vitamin D metabolism. Bile acid sequestrants may bind fat‑soluble vitamins, reducing vitamin D absorption if taken concurrently. Patients should consult healthcare providers about timing and potential adjustments when taking these medications, and clinicians often monitor serum calcium and 25‑hydroxyvitamin D levels in at‑risk individuals.

Common Forms: Vitamin D3 (cholecalciferol), Vitamin D2 (ergocalciferol), Cod liver oil

Typical Doses: 600–2000 IU/day depending on status

When to Take: With largest meal of the day

Best Form: Vitamin D3 (cholecalciferol)

⚠️ Interactions: Orlistat, Phenytoin/anticonvulsants, Thiazide diuretics, Digoxin